Skip to main content

BlackRock, Inc.

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 2012383 New York, NY

Position in KNSA

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$175,198,373
+$151,761,994 QoQ
Shares Held
2,739,615
+462.9% QoQ
Ownership
1.76%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 266 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $21,635,633,053 across 65 Drug Manufacturers - Specialty & Generic names. KNSA ranks #19 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KNSA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $175,198,373 2,739,615
2026-06-30 $162,099,756 2,534,789
2026-03-31 $23,436,379 486,737
2025-12-31 $18,422,368 446,603
2025-09-30 $17,770,427 457,647
2025-06-30 $19,448,682 702,880
2025-03-31 $76,240,240 3,432,699
2024-12-31 $70,651,443 3,571,863
2024-09-30 $95,393,220 3,817,256